Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumor

Explore clinical trials studying Advanced Solid Tumor. Study availability and eligibility vary by location and protocol.

514 public trials 240 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumor trial results

Recruiting

A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors

NCT06533332

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Diseases, +31 more
Locations
  • Macquarie University Health Ryde, New South Wales, Australia
  • The Kinghorn Cancer Center Sydney, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
  • Cancer Research SA Adelaide, South Australia, Australia
View Trial Details
Recruiting

Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors

NCT04145622

Conditions
Advanced Solid Tumor, Malignant Solid Tumor, Neoplasms
Locations
  • Cedars-Sinai Medical Center- Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Orlando, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 28 locations
View Trial Details
Recruiting

A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

NCT07181681

Conditions
Advanced Solid Tumor, Solid Tumors
Locations
  • The University of Texas Md Anderson Cancer Center Houston, Texas, United States
  • Next Oncology San Antonio, Texas, United States
  • Next Virginia Fairfax, Virginia, United States
  • Blacktown Cancer and Haematology Centre Blacktown, New South Wales, Australia
View all 14 locations
View Trial Details
Recruiting

A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors

NCT05329103

Conditions
Advanced Solid Tumor
Locations
  • HonorHealth Research Institiute Scottsdale, Arizona, United States
  • Stanford Cancer Center Palo Alto, California, United States
  • Carolina BioOncology Institute Huntersville, North Carolina, United States
  • Abramson Cancer Center at Pennsylvania Hospital Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT06172478

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +70 more
Locations
  • City of Hope Duarte, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • AdventHealth Medical Group Oncology Research at Celebration Kissimmee, Florida, United States
  • University of Illinois Cancer Center Chicago, Illinois, United States
View all 85 locations
View Trial Details
Recruiting

A Study of DS5361b in Participants With Advanced Solid Tumors

NCT07182591

Conditions
Advanced Solid Tumor
Locations
  • Research Site Sarasota, Florida, United States
  • Research Site Providence, Rhode Island, United States
  • Research Site Irving, Texas, United States
  • Research Site San Antonio, Texas, United States
View Trial Details
Recruiting

Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors

NCT05901285

Conditions
Advanced Solid Tumor, Advanced Solid Tumors Appropriate for Treatment With Either Nivolumab or Pembrolizumab
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • George Washington University Washington D.C., District of Columbia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions